La Food and Drug Administration (FDA) approuve la commercialisation de l’AMX0035 (Amylyx) pour le marché américain
Au cours de la réunion de la commission consultative sur les médicaments…
![Restez en [u]contact[/u]](/static/paper-plane.svg)
Measuring treatment effects based on patient preference
To evaluate the effect of an investigational drug in ALS clinical trials,…
TRICALS Enrols First Participants in Phase 3 MAGNET platform trial for ALS
TRICALS (the Treatment Research Initiative to Cure ALS), in collaboration with ALS…
USA: new law promises $100 million for ALS research
A new law has been passed in the United States to give…
Congratulations to our TRICALS colleagues as UK Government invests £50 million to find a cure for ALS
The UK government has recently announced that £50 million will be invested…
A road map for digital health care technology in MND
The COVID-19 pandemic has had an important impact on the development and…
Amylyx Pharmaceuticals and TRICALS to collaborate on phase 3 clinical trial
Today, Amylyx Pharmaceuticals provided an update on its plans to advance its…
Newsletter December 2020
2020 has been a difficult year for everyone. However, despite the many…